Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | +2.64% | -2.93% | -22.92% |
16/04 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
16/04 | Omega Therapeutics, Inc. Announces Executive Changes, Effective as of May 31, 2024 | CI |
Business Summary
Number of employees: 94
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Programmable Epigenomic mRNA Medicines
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +49.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01/19/01 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 23/22/23 |
Chief Tech/Sci/R&D Officer | - | 01/21/01 | |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Ling Zeng
ADM | Chief Administrative Officer | 55 | 30/22/30 |
Thomas McCauley
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/19/01 |
Yan Moore
CTO | Chief Tech/Sci/R&D Officer | 58 | 10/22/10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 01/21/01 |
John Mendlein
BRD | Director/Board Member | 64 | 01/20/01 |
Christian Schade
CHM | Chairman | 63 | 10/23/10 |
Mary Szela
BRD | Director/Board Member | 61 | 01/19/01 |
Richard Young
BRD | Director/Board Member | 70 | 01/17/01 |
Michelle Werner
BRD | Director/Board Member | - | 28/23/28 |
Elliott Levy
BRD | Director/Board Member | 64 | 01/21/01 |
Rainer Boehm
BRD | Director/Board Member | 63 | 01/22/01 |
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,154,985 | 50,558,255 ( 91.67 %) | 0 | 91.67 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.92% | 125M | |
+2.56% | 42.75B | |
+47.70% | 41.61B | |
+11.99% | 41.34B | |
-8.83% | 26.59B | |
+7.36% | 25.49B | |
-22.59% | 18.12B | |
+30.61% | 12.24B | |
-1.85% | 11.76B | |
+9.10% | 11B |
- Stock Market
- Equities
- OMGA Stock
- Company Omega Therapeutics, Inc.